CC BY 4.0 · Journal of Coloproctology 2024; 44(01): e75-e79
DOI: 10.1055/s-0044-1785211
Case Report

Vegetating Lesions that Appear in the Scar after Neoadjuvant Therapy for Rectal Tumors: Tumor Regrowth or Benign Neoplasm?

1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
Guilherme Mattiolli Nicollelli
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
Maria Cristina Sartor
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
Antonio Sergio Brener
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
Wagner Carignano Winter
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
Ygor Degraf
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
Lucas Schultz Zago
1   Division of Colorectal Surgery, Complexo Hospital de Clínicas, Universidade Federal do Paraná (CHC-UFPR), Curitiba, PR, Brazil
,
2   Division of Gastrointestinal Surgery, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
› Author Affiliations

Abstract

Introduction After the diagnosis of neoplasm of the middle and distal rectum, patients are often submitted to oncological treatment by neoadjuvant therapy. At the end of this treatment, those patients who show complete clinical response can choose, together with their physician, to adopt the watch-and-wait strategy; although it implies lower morbidity for the patient, this strategy is dependent on strict adherence to treatment follow-up for the early identification of any future local injury.

Materials and Methods Survey of data from medical records and description, and discussion of case reports with a literature review in books and databases.

Results We report the case of a 73-year-old patient diagnosed with moderately differentiated adenocarcinoma of the middle rectum, Stage II (cT3bN0M0), who presented complete clinical response after undergoing treatment with neoadjuvant therapy.

Together with the assistant team, the watch-and-wait strategy was chosen. During the follow-up, an endoscopic examination showed a vegetating at the proximal limit of the tumor scar. We chose to perform submucosal endoscopic dissection. The report of the anatomopathological examination evidenced a serrated adenoma with narrow margins free of neoplasia.

Conclusion Patient adherence to cancer treatment using the watch-and-wait strategy is essential for the early identification of new local lesions. After resection of the lesion identified in the tumor scar site as a neoplasm-free lesion, it is consistent to think that this lesion would be the origin of the neoplasm, given the adenomatous origin.



Publication History

Received: 02 August 2023

Accepted: 10 January 2024

Article published online:
11 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Habr-Gama A, Sabbaga J, Gama-Rodrigues J. et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?. Dis Colon Rectum 2013; 56 (10) 1109-1117 DOI: 10.1097/DCR.0b013e3182a25c4e.
  • 2 Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep 2018; 14 (02) 37-55 DOI: 10.1007/s11888-018-0398-5.
  • 3 Habr-Gama A, Perez RO, Lynn PB, Scanavini Neto A, Gama-Rodrigues J. Nonoperative Management of Distal Rectal Cancer After Chemoradiation: Experience with the “Watch & Wait” Protocol. 2011. DOI: 10.5772/38817
  • 4 Nasir I, Fernandez L, Vieira P. et al. Salvage surgery for local regrowths in Watch & Wait - Are we harming our patients by deferring the surgery?. Eur J Surg Oncol 2019; 45 (09) 1559-1566 DOI: 10.1016/j.ejso.2019.04.006.
  • 5 van der Sande ME, Figueiredo N, Beets GL. Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer. Ann Surg 2021; 274 (06) e1056-e1062 DOI: 10.1097/SLA.0000000000003738.
  • 6 Wang QX, Zhang R, Xiao WW. et al. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy. Radiat Oncol 2021; 16 (01) 16 DOI: 10.1186/s13014-021-01746-0.
  • 7 Haak HE, Žmuc J, Lambregts DMJ. et al; Dutch Watch-and-Wait Consortium. The evaluation of follow-up strategies of watch-and-wait patients with a complete response after neoadjuvant therapy in rectal cancer. Colorectal Dis 2021; 23 (07) 1785-1792 DOI: 10.1111/codi.15636.
  • 8 D'Alimonte L, Bao QR, Spolverato G. et al. Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Ann Surg Oncol 2021; 28 (05) 2801-2808 DOI: 10.1245/s10434-020-09243-6.
  • 9 Fernandez LM, Figueiredo NL, Habr-Gama A. et al. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?. Dis Colon Rectum 2020; 63 (08) 1053-1062 DOI: 10.1097/DCR.0000000000001707.
  • 10 Rupinski M, Szczepkowski M, Malinowska M. et al. Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign. Eur J Surg Oncol 2016 ; 42(2):288–296 10.1016/j.ejso.2015.09.022 PubMed